DrugGen
#Healthcare (Pharma Ops)
#Healthcare
Practice this advanced strategic decision case interview question from Kearney in the Healthcare (Pharma Ops) sector. Includes detailed problem prompt, clarifying questions, structured framework, and expert recommendation. Part of ProHub's 835+ consulting case library.
ProHub Comment
This is a candidate-led comparison case requiring structured analysis of a packaging innovation decision for an oncology drug. The case tests the candidate's ability to evaluate financial and non-financial factors, conduct brainstorming around operational implications, and synthesize insights into a clear recommendation with risk mitigation. The 15-20 minute timeframe demands efficient prioritization and on-the-fly idea generation.
Estimated Time
36 minutes
Difficulty
Hard
Source
PeterK
22
/ 100
DrugGen is a U.S.-based drug company. Given trends toward patient compliance and eco-friendliness, they are considering changing the packaging of an oncology drug. After assessing a lot of options (plastic bottles, parenteral containers, blister packaging, pens, etc.) through a set of strict requirements (like cold storage, enhanced protection against moisture, oxygen and other gases, unit-dose control, counterfeit protection, child-resistant properties, and cost efficiency) DrugGen identified a potential new cold chain tech packaging. The CEO has hired you to suggest if they should go for it.
Clarifying Information
- New packaging comprises a low temperature container
- Patients take 4 pills of this drug and then 2 additional generic steroids per day
- Five other pharma companies offer similar oncology drugs
- DrugGen distributes this drug globally
- DrugGen captures 1-2% of the global market, or 20k units of drug per year
- The drug’s price is $4k for monthly supply (120 pills)
- The patient population for this cancer type isn’t expanding
- No specific goals provided